A crucial factor of regenerative medicine and drug discovery lies in the ability to multiply human stem cell populations to sufficient amounts for therapeutic uses. Traditionally, limited cell presence posed a significant obstacle to progress in these fields. Consequently, considerable endeavor has been directed towards optimizing protocols for ste